Reuters Stock Buzz Powered by SocialPicks Logo_divider Logo_thomsonreuters Bg_dots_d1
   Sign Up   |   Log In   |   What is Reuters Stock Buzz?   |   FAQ powered by Logo_powered_by_socialpicks

 Aspreva Pharmaceuticals Corp  (ASPV)     Rate ASPV  -  Discuss ASPV  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate ASPV:



ASPV: Bull or Bear?

-18.01%
 risk: low
bottomed out  07/06/07
should climb over 20.   just went down after the drug trial came out.  good short term stock and they have tons of cash

Fitbusinessmannewsletter
-9.88%
 risk: low
ASPV is a BUY  04/20/07
We really like the underlying value of this company and it's consistent track record for earnings shows us that the company may be a big sleeper in our value investing strategies. http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/04-18-2007/0004568817&EDATE= spreva Pharmaceuticals Corporation (Aspreva) is a pharmaceutical company focused on identifying, d...

+20.35%
 risk: high
Is Aspreva's P/E Relevant ?  03/19/07
What does Aspreva Pharmaceuticals (ASPV) have in common with a mining company? I bet you would answer none and ridicule at me for posing such a silly question. That is just fair. But given it is trading at a P/E (ttm) of 5.9 (as of this writing), I'm sure you would agree with me that ASPV is valued no different than a boring mining stock by the street. When a mining company has limited proven ...




People Bullish on ASPV

Dennis P
Analyst
 5 %
8 mos ago

jaglow
Analyst
N/A
11 mos ago

paiguy24
Analyst
55%
12 mos ago

Cjwilks
Analyst
12%
about 1 year ago

Avenegas
Analyst
 7 %
about 1 year ago


People Bearish on ASPV

 


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Aspreva Pharmaceuticals Corp - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters